Back to results
CompletedPhase 3

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients

NCT03079219

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Department of Clinical Oncology, Prince of Wales Hospital

Hong Kong, Hong Kong

View on ClinicalTrials.gov
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer Patients — TrialFind